Kromek Group plc (GB:KMK) has released an update.
Kromek Group plc, a leader in radiation and bio-detection technology, has delayed its full year results announcement for FY 2024 to the second half of October. The Group has reported positive momentum with an expected positive EBITDA, surpassing market expectations due to improved gross margins and operational efficiencies in manufacturing. Full details on the financial outcomes and further growth strategies will be released with the final results.
For further insights into GB:KMK stock, check out TipRanks’ Stock Analysis page.
